Showing results (101-110 of 494) with videos related to

Sort By:
Pageof 50
Plos Medicine|January 4, 2017
Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act CoverageAaron S Kesselheim, Carolyn L Treasure, Steven Joffe
The Journal of Antimicrobial Chemotherapy|November 19, 2025
The curious constraints on clofazimineMaple Goh, Daniel Eisenkraft Klein, Aaron S Kesselheim
Plos Medicine|June 2, 2011
Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic reviewKirsten E Austad, Jerry Avorn, Aaron S Kesselheim
Perspectives in Biology and Medicine|May 12, 2015
Evidence, errors, and ethicsFranklin G Miller, Steven Joffe, Aaron S Kesselheim
Health Affairs (Project Hope)|October 6, 2010
Designing comparative effectiveness research on prescription drugs: lessons from the clinical trial literatureDave A Chokshi, Jerry Avorn, Aaron S Kesselheim
JAMA Network Open|January 25, 2023
Variation in Use of Lung Cancer Targeted Therapies Across State Medicaid Programs, 2020-2021Thomas J Roberts, Aaron S Kesselheim, Jerry Avorn
Journal of Managed Care & Specialty Pharmacy|January 31, 2019
New Drug Formulations and Their Respective Generic Entry DatesReed F Beall, Aaron S Kesselheim, Ameet Sarpatwari
JAMA|January 15, 2020
FDA Approval and Regulation of Pharmaceuticals, 1983-2018Jonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
Pageof 50